Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests

por Bartels, Bart, Habets, Laura E., Stam, Marloes, Wadman, Renske I., Wijngaarde, Camiel A., Schoenmakers, Marja A. G. C., Takken, Tim, Hulzebos, Erik H.J., van der Pol, W. Ludo, de Groot, Janke F.
Publicado 2019

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPA...

por Stam, Marloes, Wadman, Renske I, Wijngaarde, Camiel A, Bartels, Bart, Asselman, Fay-Lynn, Otto, Louise A M, Goedee, H Stephan, Habets, Laura E, de Groot, Janke F, Schoenmakers, Marja A G C, Cuppen, Inge, van den Berg, Leonard H, van der Pol, W Ludo
Publicado 2018

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study

por Scheijmans, Féline E V, Cuppen, Inge, van Eijk, Ruben P A, Wijngaarde, Camiel A, Schoenmakers, Marja A G C, van der Woude, Danny R, Bartels, Bart, Veldhoen, Esther S, Oude Lansink, Irene L B, Groen, Ewout J N, Asselman, Fay-Lynn, Wadman, Renske I, van der Pol, W Ludo
Publicado 2022

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4

por Stam, Marloes, Wijngaarde, Camiel A, Bartels, Bart, Asselman, Fay-Lynn, Otto, Louise A M, Habets, Laura E, van Eijk, Ruben P A, Middelkoop, Bas M, Goedee, H Stephan, de Groot, Janke F, Roes, Kit C B, Schoenmakers, Marja A G C, Nieuwenhuis, Edward E S, Cuppen, Inge, van den Berg, Leonard H, Wadman, Renske I, van der Pol, W Ludo
Publicado 2022